U.S. flag

An official website of the United States government

NM_024854.5(PYROXD1):c.84+11G>T AND not provided

Germline classification:
Likely benign (1 submission)
Last evaluated:
Dec 3, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003547362.1

Allele description

NM_024854.5(PYROXD1):c.84+11G>T

Gene:
PYROXD1:pyridine nucleotide-disulphide oxidoreductase domain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p12.1
Genomic location:
Preferred name:
NM_024854.5(PYROXD1):c.84+11G>T
HGVS:
  • NC_000012.12:g.21437825G>T
  • NG_053196.1:g.5222G>T
  • NG_188159.1:g.312G>T
  • NM_001350913.2:c.-620+11G>T
  • NM_024854.5:c.84+11G>TMANE SELECT
  • NC_000012.11:g.21590759G>T
Molecular consequence:
  • NM_001350913.2:c.-620+11G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_024854.5:c.84+11G>T - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Clear Turn Off Turn On
  • Parasagitta elegans voucher 40 small subunit ribosomal RNA gene, partial sequenc...
    Parasagitta elegans voucher 40 small subunit ribosomal RNA gene, partial sequence
    gi|2047800935|gb|MZ333547.1|
    Nucleotide
  • Pyonephrosis
    Pyonephrosis
    Distention of KIDNEY with the presence of PUS and suppurative destruction of the renal parenchyma. It is often associated with renal obstruction and can lead to total or nearl...<br/>Year introduced: 2007
    MeSH
  • Pseudohypoaldosteronism
    Pseudohypoaldosteronism
    A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertens...<br/>Year introduced: 1991(1988)
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004252344Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Likely benign
(Dec 3, 2023) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV004252344.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024